NCT07012512View on ClinicalTrials.gov

Adjusted Study Protocol: Within-Subject Paired-Eye Design Comparing Pilocarpine 0.1%, Phentolamine 0.75%, and Combination Therapy for Cyclopentolate Reversal in Children

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 30, 2025

Conditions
Pupillary ConstrictionAccomodation
Interventions
DRUG

Use of phentolamine eye drops to reverse cycloplegia

Use of phentolamine 0.75% eye drops to reverse cycloplegia

DRUG

Pilocarpine 0.1%

Use of pilocarpine 0.1% to reverse cycloplegia

DRUG

Combination of pilocarpine 0.1% and phentolamine 0.75%

Combination of pilocarpine 0.1% and phentolamine 0.75%

All Listed Sponsors
lead

Mansoura University

OTHER

NCT07012512 - Adjusted Study Protocol: Within-Subject Paired-Eye Design Comparing Pilocarpine 0.1%, Phentolamine 0.75%, and Combination Therapy for Cyclopentolate Reversal in Children | Biotech Hunter | Biotech Hunter